Hualan Biological Engineering Inc(002007) vaccine Co., Ltd. independent director
On relevant matters of the 11th meeting of the first board of directors
separate opinion
In accordance with the guiding opinions on the establishment of independent director system in listed companies, the guidelines for the standardized operation of companies listed on the gem of Shenzhen Stock Exchange and other laws and regulations, as well as the articles of association and other relevant provisions, we are the independent directors of Hualan Biological Engineering Inc(002007) vaccine Co., Ltd. (hereinafter referred to as the “company”), We have obtained and carefully reviewed the relevant proposals and materials of the 11th meeting of the first board of directors of the company. Based on the position of objective and independent judgment, we express independent opinions on the relevant matters of the 11th meeting of the first board of directors of the company as follows:
1、 Independent opinions on the proposal on using raised funds to replace self raised funds invested in raised investment projects in advance and paid issuance expenses
After examination, we believe that: the company has performed the necessary approval procedures to replace the self raised funds invested in the raised funds investment projects in advance and paid the issuance expenses with the raised funds, which does not conflict with the implementation plan of the raised funds investment projects, does not affect the normal progress of the raised funds investment projects, and does not change the purpose of the raised funds and damage the interests of shareholders in a disguised manner. We agree to use the raised funds to replace the self raised funds invested in the raised investment projects in advance and the paid issuance expenses.
2、 Independent opinions on the proposal on using some idle raised funds for cash management
After review, we believe that the use of some idle raised funds for cash management this time, Comply with relevant normative documents such as the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, the Listing Rules of GEM stocks of Shenzhen Stock Exchange, the guidelines for the self-discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of GEM listed companies, and the provisions of the company’s measures for the administration of raised funds. Without affecting the construction progress of the raised funds and the normal operation of the company, the rational use of idle raised funds for cash management is conducive to improving the use efficiency of the company’s funds, increasing the return of funds, and obtaining more returns for the company and shareholders, without damaging the interests of the company and minority shareholders. This matter has fulfilled the necessary approval and verification procedures, and there is no situation of changing the use purpose of the raised funds in a disguised form, which will not affect the normal progress of the investment plan of the raised funds. We agree that the company uses some idle raised funds for cash management.
Independent directors: Li Dexin, Dong guanmu, Yang Dongsheng March 4, 2022
